These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 13317645)

  • 1. [Metastasizing carcinoid of the small intestine with detection of hydroxyindoleacetic acid in blood and urine by high tension electrophoresis].
    HEILMEYER L; KUHN HA; CLOTTEN R; LIPP A
    Dtsch Med Wochenschr; 1956 Apr; 81(14):501-3. PubMed ID: 13317645
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical manifestations and detection of 5-hydroxy-indolacetic acid and 5-hydroxy-tryptamine in metastasizing carcinoid of the small intestine].
    HEGGLIN R; LANGEMANN H
    Helv Med Acta; 1955 Nov; 22(4-5):463-9. PubMed ID: 13285817
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of chlorpromazine on excretion of 5-hydroxyindoleacetic acid in a patient with malignant carcinoid.
    BERTINO GG; COLE JW
    Proc Soc Exp Biol Med; 1956 Oct; 93(1):100-2. PubMed ID: 13370589
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine aspects of argentaffinoma, with special reference to the use of urinary 5-hydroxyindoleacetic acid estimations in diagnosis.
    MACFARLANE PS; DALGLIESH CE; DUTTON RW; LENNOX B; NYHUS LM; SMITH AN
    Scott Med J; 1956 Apr; 1(4):148-55. PubMed ID: 13324175
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of various methods for quantitative determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in a case of metastasizing carcinoid of the small intestine.
    ZYLKA W; KOHLER T
    Klin Wochenschr; 1957 Jun; 35(12):622-6. PubMed ID: 13450282
    [No Abstract]   [Full Text] [Related]  

  • 6. Metastasizing carcinoid and 5-hydroxytryptamine.
    JENSEN K
    Dan Med Bull; 1957 May; 4(3):96-101. PubMed ID: 13437704
    [No Abstract]   [Full Text] [Related]  

  • 7. [Additional remarks on the detection of 5-hydroxyindoleacetic acid, with some notes on the paper A simple test for diagnosis of metastatic carcinoma].
    TEICHMANN W; SCHMIDT G
    Z Gesamte Inn Med; 1957 Apr; 12(7):327-8. PubMed ID: 13456735
    [No Abstract]   [Full Text] [Related]  

  • 8. [Suppression of hydroxyindole-acetic acid excretion in urine after reserpine administration in humans; with special consideration to carcinoid syndrome].
    LANGEMANN H; GOERRE J
    Schweiz Med Wochenschr; 1957 May; 87(21):607-11. PubMed ID: 13442615
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the urine test for serotonin metabolites.
    MOHLER DN
    J Am Med Assoc; 1957 Mar; 163(13):1138. PubMed ID: 13405778
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of 5-hydroxy-indole-acetic acid in urine; and its excretion in patients with malignant carcinoids.
    HANSON A; SERIN F
    Lancet; 1955 Dec; 269(6905):1359-61. PubMed ID: 13279137
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary 5-hydroxyindole acetic acid and treatment of carcinoid of the rectum. Report of one case.
    AHLGREN M; WIKLANDER O
    Acta Chir Scand; 1962 Nov; 124():461-6. PubMed ID: 14011333
    [No Abstract]   [Full Text] [Related]  

  • 12. A rapid chromatographic test for high urinary excretion of 5-hydroxy-indole-acetic acid and 5-hydroxytryptamine.
    CURZON G
    Lancet; 1955 Dec; 269(6905):1361-2. PubMed ID: 13279138
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral effects of metastasising carcinoid tumours.
    SNOW PJ; LENNARD-JONES JE; CURZON G; STACEY RS
    Lancet; 1955 Nov; 269(6898):1004-9. PubMed ID: 13272318
    [No Abstract]   [Full Text] [Related]  

  • 14. PRIMARY OVARIAN CARCINOID TUMORS: CASE REPORT AND REVIEW OF THE LITERATURE.
    DOUCHETTE JW; ESTES WB
    Obstet Gynecol; 1965 Jan; 25():94-101. PubMed ID: 14242557
    [No Abstract]   [Full Text] [Related]  

  • 15. TUMORS OF THE SMALL INTESTINE.
    BRAASCH JW; DENBO HE
    Surg Clin North Am; 1964 Jun; 44():791-809. PubMed ID: 14183817
    [No Abstract]   [Full Text] [Related]  

  • 16. CLINICAL AND BIOCHEMICAL EFFECTS OF CYCLOPHOSPHAMIDE IN PATIENTS WITH MALIGNANT CARCINOID.
    MENGEL CE; KELLY MG; CARBONE PP; ANLYAN WG
    Am J Med; 1965 Mar; 38():396-404. PubMed ID: 14266830
    [No Abstract]   [Full Text] [Related]  

  • 17. THORSON BIOERCK SYNDROME WITH HIGH LEVELS OF 5 HYDROXYINDOLEACTEIC ACID WITHOUT CARCINOID TUMOR.
    WIDELITZ MM; RYBACHOK TH
    J Germantown Hosp; 1964 Apr; 5():32-42. PubMed ID: 14144718
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON A CASE OF METASTATIC FUNCTIONING ILEAL CARCINOID. OBSERVATIONS AND CONSIDERATIONS 3 YEARS AFTER SURGICAL INTERVENTION].
    PICCHIOTTI R; PIETROPAOLO C; ROCCHI V
    Gazz Int Med Chir; 1963 Dec; 67():SUPPL:3685-94. PubMed ID: 14184077
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and biochemical studies in the carcinoid syndrome].
    BLUMBERG A; DUBACH UC; KREIS W; MUELLER HR
    Dtsch Med Wochenschr; 1962 May; 87():921-9. PubMed ID: 13870227
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoid syndrome associated with hyperserotoninemia and normal 5-hydroxyindoleacetic acid excretion.
    DAVIS RB; ROSENBERG JC
    Am J Med; 1961 Jan; 30():167-74. PubMed ID: 13720235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.